Zonisamide Capsule
Product Images NDC 60687-230

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 60687-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp23001

FDA Label Image

Blister

Zonisamide is a medication that comes in several strengths (700 mg, 406 mg, 730 mg, 600 mg) and formulations (Capatio, Gapaute, Ganatte, Capsife). The provided text lists various 10-digit codes, possibly related to prescriptions or packaging.*

FDA Label Image

Carton

Zonisamide is a drug available in capsules form, used to treat certain types of seizures. The medication should be taken under the advice of a medical practitioner. The packaging contains 100 capsules, and the usual dosage can be found inside the package. The storage condition is between 20°C to 25°C, in a dry place and protected from light. The drug should be kept away from children, and the pharmacist should provide each patient with a medication guide. The drug product is from Cipla USA, Inc., and packaged and distributed by American Health Packaging.*

FDA Label Image

Figure 1

FDA Label Image

Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.